Keyphrases
Glaucoma
100%
Retinal Ganglion Cells
59%
Optic Nerve
42%
Optic Nerve Transection
40%
Intraocular Pressure
39%
Experimental Glaucoma
35%
Pseudoexfoliation Syndrome
34%
Retina
32%
Secondary Degeneration
29%
Minocycline
24%
Retinal Ganglion Cell Death
21%
Glaucomatous
20%
Visual Acuity
18%
Israel
16%
Human Mesenchymal Stem Cells (hMSCs)
15%
Rat Model
15%
Intraocular Pressure Elevation
15%
Primary Open-angle Glaucoma
15%
Maccabi
14%
Cataract
14%
Pro-survival Genes
13%
Apoptotic Genes
12%
Elevated Intraocular Pressure
12%
Immunohistochemistry
12%
Mitomycin C
12%
Pseudoexfoliation Glaucoma
11%
Surgical Management
11%
Neuroprotection
11%
Glaucoma Patients
11%
Israeli
11%
Cataract Surgery
11%
Health Maintenance Organizations
10%
Optic Nerve Injury
10%
Optic Nerve Head
10%
Glaucoma Medication
10%
Transection
9%
Inhibitor of Apoptosis Proteins
9%
Rat Eye
9%
Ranibizumab
9%
Retinal Degeneration
9%
Transplantation
9%
Contrast Sensitivity
9%
After Cataract
9%
Mesopic
9%
Angiography
9%
Cell Death Pathways
9%
Cell Survival Pathways
9%
Clusterin
9%
Neuroprotective
9%
Glaucoma Treatment
8%
Neuroscience
Glaucoma
98%
Optic Nerve
84%
Retinal Ganglion Cell
72%
Intraocular Pressure
38%
Cell Death
30%
Minocycline
24%
Neuroprotective Agent
20%
Programmed Cell Death
18%
Neuroprotection
15%
Immunohistochemistry
14%
Cell Survival
13%
Nerve Injury
11%
Ocular Hypertension
11%
Open-Angle Glaucoma
10%
Bevacizumab
9%
Clusterin
9%
Ranibizumab
9%
Bcl-2
9%
Mitogen-Activated Protein Kinase
9%
Caspase
8%
Western Blot
8%
Axon
7%
Optic Neuropathy
7%
Caspase 3
7%
X Linked Inhibitor of Apoptosis
7%
Phosphoinositide 3-Kinase
7%
Gene Expression
7%
Diabetes Mellitus
6%
Trabecular Meshwork
6%
Experimental Autoimmune Encephalomyelitis
6%
Amino Acid
5%
Cataract
5%
Neurotrophic Factor
5%
Oxidative Stress
5%
Multigene Family
5%
Vitreous
5%
Angiography
5%
Medicine and Dentistry
Glaucoma
59%
Intraocular Pressure
35%
Optic Nerve
34%
Pseudoexfoliation
34%
Ganglion
16%
Cataract Surgery
15%
Cataract
15%
Open Angle Glaucoma
14%
Bleeding
12%
Visual Field
12%
Mitomycin
11%
Cell Death
11%
Angiography
9%
Bone Marrow Mesenchymal Stem Cell
9%
Retina Degeneration
9%
Visual Acuity
9%
Trabeculectomy
8%
Surgeon
8%
Intravitreal Administration
7%
Neuroprotective Agent
6%
Tomography
6%
Cell Survival
6%
Trabecular Meshwork
6%
Therapy Effect
6%
Schlemm's Canal
6%
Diabetes Mellitus
6%
Nerve Transection
6%
Glaucoma Surgery
5%
Diseases
5%
Clinical Trial
5%
Neuroprotection
5%